6 Recommendations for further research

6 Recommendations for further research

6.1 The Committee concluded that further research directly comparing the clinical and cost effectiveness of ranibizumab and bevacizumab in people with macular oedema secondary to retinal vein occlusion should be conducted.

  • National Institute for Health and Care Excellence (NICE)